Clinical Trial Update: A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the tolerability and safety of PEP005 Topical Gel for actinic keratoses has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratoses

Drugs mentioned

• PEP005 Topical Gel (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratoses | Phase 2 | Status: COMPLETED